Secondary causes of osteoporosis

被引:179
作者
Fitzpatrick, LA [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Endocrine Res Unit, Div Endocrinol Diabet Metab Nutr & Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.4065/77.5.453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Secondary causes of bone loss are not often considered in patients who are diagnosed as having osteoporosis. In some studies, 20% to 30% of postmenopausal women and more than 50% of men with osteoporosis have a secondary cause. There are numerous causes of secondary bone loss, including adverse effects of drug therapy, endocrine disorders, eating disorders, immobilization, marrow-related disorders, disorders of the gastrointestinal or biliary tract, renal disease, and cancer. Patients who have undergone organ transplantation are also at increased risk for osteoporosis. In many cases, the adverse effects of osteoporosis are reversible with appropriate intervention. Because of the many treatment options that are now available for patients with osteoporosis and the tremendous advances that have been made in understanding the pathogenesis and diagnosis of the condition, it is important that medical disorders are recognized and appropriate interventions are undertaken. This article provides the framework for understanding causes of bone loss and approaches to their management.
引用
收藏
页码:453 / 468
页数:16
相关论文
共 150 条
[1]   Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma [J].
Abildgaard, N ;
Glerup, H ;
Rungby, J ;
Bendix-Hansen, K ;
Kassem, M ;
Brixen, K ;
Heickendorff, L ;
Nielsen, JL ;
Eriksen, EF .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 64 (02) :121-129
[2]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[3]  
Adachi JD, 2001, ARTHRITIS RHEUM-US, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO
[4]  
2-W
[5]   Treatment of established bone loss after renal transplantation with etidronate [J].
Arlen, DJ ;
Lambert, K ;
Ioannidis, G ;
Adachi, JD .
TRANSPLANTATION, 2001, 71 (05) :669-673
[6]   EVIDENCE OF OSTEOMALACIA IN AN OUTPATIENT GROUP OF ADULT EPILEPTICS [J].
ASHWORTH, B ;
HORN, DB .
EPILEPSIA, 1977, 18 (01) :37-43
[7]   OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS [J].
BACHRACH, LK ;
LOUTIT, CW ;
MOSS, RB ;
MARCUS, R .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (01) :27-34
[8]   FACTORS ASSOCIATED WITH APPENDICULAR BONE MASS IN OLDER WOMEN [J].
BAUER, DC ;
BROWNER, WS ;
CAULEY, JA ;
ORWOLL, ES ;
SCOTT, JC ;
BLACK, DM ;
TAO, JL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :657-665
[9]   BONE-DISEASE IN ALCOHOL-ABUSE [J].
BIKLE, DD ;
GENANT, HK ;
CANN, C ;
RECKER, RR ;
HALLORAN, BP ;
STREWLER, GJ .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :42-48
[10]  
BIKLE DD, 1999, PRIMER METABOLIC BON, P343